These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 20122454

  • 1. Dehydroepiandrosterone to enhance physical performance: myth and reality.
    Hahner S, Allolio B.
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):127-39, x. PubMed ID: 20122454
    [Abstract] [Full Text] [Related]

  • 2. The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods.
    von Mühlen D, Laughlin GA, Kritz-Silverstein D, Barrett-Connor E.
    Contemp Clin Trials; 2007 Feb; 28(2):153-68. PubMed ID: 16784898
    [Abstract] [Full Text] [Related]

  • 3. [Focus on dehydroepiandrosterone (DHEA)].
    Meyer P, Meier CA.
    Rev Med Suisse; 2005 Feb 09; 1(6):415-8. PubMed ID: 15786645
    [Abstract] [Full Text] [Related]

  • 4. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct 09; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 5. Associated hormonal declines in aging: DHEAS.
    Perrini S, Laviola L, Natalicchio A, Giorgino F.
    J Endocrinol Invest; 2005 Oct 09; 28(3 Suppl):85-93. PubMed ID: 16042365
    [Abstract] [Full Text] [Related]

  • 6. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women.
    Genazzani AR, Pluchino N, Begliuomini S, Stomati M, Bernardi F, Pieri M, Casarosa E, Palumbo M, Genazzani AD, Luisi M.
    Gynecol Endocrinol; 2006 Nov 09; 22(11):627-35. PubMed ID: 17145649
    [Abstract] [Full Text] [Related]

  • 7. Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects.
    Martina V, Benso A, Gigliardi VR, Masha A, Origlia C, Granata R, Ghigo E.
    Clin Endocrinol (Oxf); 2006 Mar 09; 64(3):260-4. PubMed ID: 16487434
    [Abstract] [Full Text] [Related]

  • 8. Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters.
    Christiansen JJ, Gravholt CH, Fisker S, Svenstrup B, Bennett P, Veldhuis J, Andersen M, Christiansen JS, Jørgensen JO.
    Clin Endocrinol (Oxf); 2004 Apr 09; 60(4):461-9. PubMed ID: 15049961
    [Abstract] [Full Text] [Related]

  • 9. Supplementation with DHEA: effect on muscle size, strength, quality of life, and lipids.
    Dayal M, Sammel MD, Zhao J, Hummel AC, Vandenbourne K, Barnhart KT.
    J Womens Health (Larchmt); 2005 Jun 09; 14(5):391-400. PubMed ID: 15989411
    [Abstract] [Full Text] [Related]

  • 10. Abuse of anabolic androgenic steroids and related substances in sport and exercise.
    Bahrke MS, Yesalis CE.
    Curr Opin Pharmacol; 2004 Dec 09; 4(6):614-20. PubMed ID: 15525553
    [Abstract] [Full Text] [Related]

  • 11. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
    Wolfarth B, Wuestenfeld JC, Kindermann W.
    Endocrinol Metab Clin North Am; 2010 Mar 09; 39(1):75-87, ix. PubMed ID: 20122451
    [Abstract] [Full Text] [Related]

  • 12. Hormonal status of cortisol and dehydroepiandrosterone sulfate in an elderly Tunisian population.
    Chehab O, Ouertani M, Chaieb K, Haouala F, Mahdouani K.
    C R Biol; 2007 Oct 09; 330(10):755-63. PubMed ID: 17905395
    [Abstract] [Full Text] [Related]

  • 13. [Hormones and osteoporosis update. Adrenal androgen and bone].
    Takayanagi R.
    Clin Calcium; 2009 Jul 09; 19(7):963-9. PubMed ID: 19567992
    [Abstract] [Full Text] [Related]

  • 14. [Replacement and supplementation of DHEA--is it a wellness hormone?].
    Brückel J.
    MMW Fortschr Med; 2005 Feb 17; 147(7):30-2. PubMed ID: 18441581
    [Abstract] [Full Text] [Related]

  • 15. Dehydroepiandrosterone replacement therapy in hypoadrenal women: protein anabolism and skeletal muscle function.
    Dhatariya KK, Greenlund LJ, Bigelow ML, Thapa P, Oberg AL, Ford GC, Schimke JM, Nair KS.
    Mayo Clin Proc; 2008 Nov 17; 83(11):1218-25. PubMed ID: 18990320
    [Abstract] [Full Text] [Related]

  • 16. Short-term Dehydroepiandrosterone Intake and Supramaximal Exercise in Young Recreationally-trained Women.
    Gravisse N, Vibarel-Rebot N, Labsy Z, Do MC, Gagey O, Dubourg C, Audran M, Collomp K.
    Int J Sports Med; 2018 Sep 17; 39(9):712-719. PubMed ID: 29940669
    [Abstract] [Full Text] [Related]

  • 17. Dehydroepiandrosterone replacement in healthy men with age-related decline of DHEA-S: effects on fat distribution, insulin sensitivity and lipid metabolism.
    Jedrzejuk D, Medras M, Milewicz A, Demissie M.
    Aging Male; 2003 Sep 17; 6(3):151-6. PubMed ID: 14628495
    [Abstract] [Full Text] [Related]

  • 18. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology.
    Labrie F, Luu-The V, Labrie C, Simard J.
    Front Neuroendocrinol; 2001 Jul 17; 22(3):185-212. PubMed ID: 11456468
    [Abstract] [Full Text] [Related]

  • 19. Doping Status of DHEA Treatment for Female Athletes with Adrenal Insufficiency.
    Handelsman DJ, Matsumoto AM, Gerrard DF.
    Clin J Sport Med; 2017 Jan 17; 27(1):78-85. PubMed ID: 26844622
    [Abstract] [Full Text] [Related]

  • 20. [Neuropsychic effects of dehydroepiandrosterone].
    Rigaud AS, Pellerin J.
    Ann Med Interne (Paris); 2001 Apr 17; 152 Suppl 3():IS43-9. PubMed ID: 11435994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.